The Nightlight Falls Prevention Study
Launched by UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL · Jul 31, 2023
Trial Information
Current as of October 17, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The Nightlight Falls Prevention Study is testing whether a subtle, low-intensity lighting system placed along doorframes and in bathrooms can help people with Alzheimer’s disease or related dementias stay steadier at night and reduce nighttime falls in assisted living. In this randomized crossover trial, 335 residents across 36 assisted living communities will experience both the new lighting and the standard night light over one year, in four different sequences. The lights will be turned on or off by research staff during planned visits, and each participant will have periods with the novel lighting and periods with the usual lighting, without long gaps between changes. Falls will be tracked with a privacy-protecting fall-detection system.
Who may be eligible? Adults with a dementia diagnosis who live in a participating assisted living community can join if they have a private room (or a certain type of shared room with a divider), are not blind, not on hospice and not expected to die or transfer in the next six months. The study is led by the University of North Carolina at Chapel Hill and aims to learn whether this simple lighting change can lower the number of nighttime falls and whether any factors about residents or their environment influence the effect. If you participate, you’ll contribute to knowledge that could improve safety and quality of life for people living with dementia in care settings. The trial is currently enrolling by invitation and is expected to finish around 2027.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Has a diagnosis of dementia
- • Lives in a participating AL community
- • Not blind
- • Not on hospice and in a worsening state
- • Not expected to die or transfer during the next 6 months
- • Reside in a private room; or reside in a shared room if
- • 1. one resident is male and one is female and both are participating in the project, or
- • 2. they are of any gender, as long as there is a wall divider between their bedrooms
- • Do not have an overnight sitter in the room every night
- Exclusion Criteria:
- • • None
About University Of North Carolina, Chapel Hill
The University of North Carolina at Chapel Hill (UNC) is a leading research institution renowned for its commitment to advancing health and science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, UNC conducts cutting-edge research across various fields, including medicine, public health, and biomedical sciences. The university is dedicated to improving patient care and health outcomes by translating its research findings into practical applications. UNC’s clinical trials are designed to evaluate new therapies, interventions, and technologies, ensuring that they meet the highest ethical and scientific standards while fostering a culture of inclusivity and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chapel Hill, North Carolina, United States
Patients applied
Trial Officials
Sheryl Zimmerman, PhD
Principal Investigator
University of North Carolina, Chapel Hill
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported